NYSE American - Nasdaq Real Time Price USD
Calidi Biotherapeutics, Inc. (CLDI)
0.4801
+0.0111
+(2.37%)
At close: April 23 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CAMAISA ALLAN Chief Executive Officer | Sale | Dec 17, 2024 | 66,712 |
| FIRST LIGHT ACQUISITION GROUP LLC Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 12, 2023 | -- |
| LEFTWICH SCOTT Director | Stock Award(Grant) | Dec 31, 2024 | 67,774 |
| SCHOENECK JAMES A Director | Stock Award(Grant) | Jun 28, 2024 | 1,071,780 |
| STEWART ALAN R Director | Stock Award(Grant) | Dec 31, 2024 | 28,976 |
| VECCHIOLLA THOMAS A Director | Stock Award(Grant) | Dec 21, 2023 | 365,105 |
| ZULUETA ALFONSO G Director | Stock Award(Grant) | Dec 21, 2023 | 133,301 |
Related Tickers
ALGS Aligos Therapeutics, Inc.
5.36
+4.28%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.8627
+13.80%
BIVI BioVie Inc.
0.8402
+3.64%
SGMT Sagimet Biosciences Inc.
2.7750
+8.82%
ACXP Acurx Pharmaceuticals, Inc.
0.3870
+2.73%
RENB Renovaro Inc.
0.3756
+7.87%
CANF Can-Fite BioPharma Ltd.
1.1800
+0.85%
ENLV Enlivex Therapeutics Ltd.
0.9200
+0.88%
SLXNW Silexion Therapeutics Corp
0.0650
-7.14%
ALLR Allarity Therapeutics, Inc.
1.0100
+1.93%